Key result
DUSP1 overexpression protected against lipopolysaccharide-induced septic cardiomyopathy in mice by improving FUNDC1-induced mitophagy and restoring mitochondrial metabolism.
Why the study?
Dual specificity phosphatase 1 is considered an anti-inflammatory factor, but whether it attenuates inflammation-induced cardiomyopathy by improving mitophagy was unknown.
Does DUSP1 overexpression attenuate inflammation-induced cardiomyopathy in lipopolysaccharide-treated mice?
Population
WT mice and freshly isolated single cardiomyocytes treated with lipopolysaccharide
Comparison
DUSP1 overexpression vs control
Design
Preclinical animal and cellular experimental study
Authors
Loading...
DUSP1 enhancement may protect against septic cardiomyopathy in mice; hypothesis-generating and leaves open any clinical translation.
Does DUSP1 overexpression attenuate inflammation-induced cardiomyopathy in lipopolysaccharide-treated mice?
DUSP1 protects against septic cardiomyopathy by improving FUNDC1-induced mitophagy, highlighting a potential therapeutic target for inflammation-induced heart dysfunction.
Tan et al. (2022) studied Septic cardiomyopathy. DUSP1 overexpression vs. Wild-type control was evaluated on Heart function and mitochondrial metabolism. DUSP1 overexpression protected against lipopolysaccharide-induced septic cardiomyopathy in mice by improving FUNDC1-induced mitophagy and restoring mitochondrial metabolism.
Synapse has enriched one closely related paper. Consider it for comparative context: